company background image
FME logo

Fresenius Medical Care XTRA:FME Stock Report

Last Price

€36.30

Market Cap

€10.7b

7D

0.2%

1Y

-25.4%

Updated

17 Jul, 2024

Data

Company Financials +

Fresenius Medical Care AG

XTRA:FME Stock Report

Market Cap: €10.7b

FME Stock Overview

Provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally.

FME fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends5/6

Fresenius Medical Care AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fresenius Medical Care
Historical stock prices
Current Share Price€36.30
52 Week High€49.62
52 Week Low€30.16
Beta0.86
11 Month Change-2.37%
3 Month Change-0.36%
1 Year Change-25.42%
33 Year Change-46.82%
5 Year Change-47.35%
Change since IPO121.57%

Recent News & Updates

Recent updates

These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

Jun 17
These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

May 30
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

May 10
Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Apr 26
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 29
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Mar 14
Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Feb 23
Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Feb 22
When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Feb 03
Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Jan 16
Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Dec 29
Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Nov 21
Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Oct 16
Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 28
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Aug 21
Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Jul 23
An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

Jul 09
Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

Jun 25
These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

May 07
What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

Apr 23
Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Mar 24
We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Feb 03
Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Jan 19
Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Jan 04
Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Dec 17
Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Nov 08
Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Shareholder Returns

FMEDE HealthcareDE Market
7D0.2%1.8%1.2%
1Y-25.4%-4.2%2.7%

Return vs Industry: FME underperformed the German Healthcare industry which returned -4.2% over the past year.

Return vs Market: FME underperformed the German Market which returned 2.7% over the past year.

Price Volatility

Is FME's price volatile compared to industry and market?
FME volatility
FME Average Weekly Movement4.6%
Healthcare Industry Average Movement4.8%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.6%
10% least volatile stocks in DE Market2.5%

Stable Share Price: FME has not had significant price volatility in the past 3 months.

Volatility Over Time: FME's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996117,128Helen Gizawww.freseniusmedicalcare.com

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.

Fresenius Medical Care AG Fundamentals Summary

How do Fresenius Medical Care's earnings and revenue compare to its market cap?
FME fundamental statistics
Market cap€10.65b
Earnings (TTM)€483.59m
Revenue (TTM)€19.47b

22.0x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FME income statement (TTM)
Revenue€19.47b
Cost of Revenue€14.52b
Gross Profit€4.95b
Other Expenses€4.47b
Earnings€483.59m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 30, 2024

Earnings per share (EPS)1.65
Gross Margin25.42%
Net Profit Margin2.48%
Debt/Equity Ratio52.5%

How did FME perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

72%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.